生物科技指数破4年新高！NVO，你看好吗？ - 老虎社区

09:19

小资金就算了，大资金可以继续看好

鹿鼎公韦小宝

11-13 20:25

礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 $诺和诺德(NVO)$

买股票的打铁匠

11-13 20:24

这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 $诺和诺德(NVO)$

11-13 14:49

诺和诺德看好，但是不敢买。主要还不熟悉美股

沙漠追光大海逐风

11-13 14:37

$诺和诺德(NVO)$Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。

艳阳高照天

11-13 14:36

$诺和诺德(NVO)$决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。

11-13 11:31

之前45左右持有过，小赚一笔，弹性确实不如礼来

08-26

没有买， 0成本。再看看

08-20

老板拿了多少，啥价格啊

08-20

没有买入，估值有点不敢入手。

重生之我是鲍威尔

08-19

这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 $诺和诺德(NVO)$

08-19

降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 $诺和诺德(NVO)$

08-19

没有买[笑哭] [笑哭] 看着勇士们发财。

沙漠追光大海逐风

08-19

$诺和诺德(NVO)$感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……

艳阳高照天

08-19

$诺和诺德(NVO)$司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块

画夕阳非晚

08-13

哈哈哈哈驴肉火烧确实好吃，刚去保定吃

08-12

都不抄底，等机会。宁可错过，不要做错。

08-11

耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 $诺和诺德(NVO)$

艳阳高照天

08-11

$礼来(LLY)$礼来都估算600企稳，580最低是吧，那我就估算500-550吧，预估大家的预估求稳还是入XLV吧

糊涂虫141319

08-11

错杀那么好的公司，业绩也好，利润也好

{"data":{"themeId":"73e1dea489bd4d1b9c97363645435831","name":"生物科技指数破4年新高！NVO，你看好吗？","description":"诺和诺德两日大涨近10%，主要是昨天公布了两个重磅产品的临床试验数据，再加上市场对12月份美国降息预期增加，直接推动美股创新药指数大涨，也带动美股生物科技指数，破4年新高。【大家觉得诺和诺德还有多大上涨空间？医药板块后市你看好吗？】","image":"https://static.tigerbbs.com/e4b46bcab7704932bd005a8ebd30a750","type":0,"style":1,"follow":false,"createTime":1753843294330,"userCounts":7,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":73e1dea489bd4d1b9c97363645435831}&rnconfig={\"headerBarHidden\": true}","subscribe":false,"allowFollow":true,"hasReward":true,"rewardScore":1000,"rewardValidDate":1763481600000,"rewardEnd":false,"symbols":[],"tweetCounts":75,"categoryId":"d316d8bd4a714fab9ea15fd7157c45e7","options":[],"votedOptionId":"","totalUserCount":0,"followStatus":false,"themeName":"生物科技指数破4年新高！NVO，你看好吗？","tweetAmount":75,"imageIsDefault":false,"aiDerivativeIssues":[]},"tab":"all","allList":[{"id":500240556270240,"gmtCreate":1763169542636,"gmtModify":1763169544997,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"title":"","htmlText":"小资金就算了，大资金可以继续看好","listText":"小资金就算了，大资金可以继续看好","text":"小资金就算了，大资金可以继续看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/500240556270240","isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499829382222216,"gmtCreate":1763036749120,"gmtModify":1763036751237,"author":{"id":"10000000000010491","authorId":"10000000000010491","name":"鹿鼎公韦小宝","avatar":"https://static.tigerbbs.com/acbcdba23abf01629ff9868ac714915f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010491","authorIdStr":"10000000000010491"},"themes":[],"htmlText":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499829382222216","isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499829144248712,"gmtCreate":1763036691021,"gmtModify":1763036693309,"author":{"id":"10000000000010487","authorId":"10000000000010487","name":"买股票的打铁匠","avatar":"https://static.tigerbbs.com/6d94a0a25c35b5c7cdb89db84b17cf5c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010487","authorIdStr":"10000000000010487"},"themes":[],"htmlText":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499829144248712","isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499677619126864,"gmtCreate":1763016562147,"gmtModify":1763016564839,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"title":"","htmlText":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","listText":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","text":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499677619126864","isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499743670444424,"gmtCreate":1763015823394,"gmtModify":1763015825593,"author":{"id":"9000000000000220","authorId":"9000000000000220","name":"沙漠追光大海逐风","avatar":"https://static.tigerbbs.com/e30b7f24ce0a6599dcdfa3567f958dea","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000220","authorIdStr":"9000000000000220"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","text":"$诺和诺德(NVO)$Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499743670444424","isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499743512887688,"gmtCreate":1763015784927,"gmtModify":1763015787212,"author":{"id":"9000000000000219","authorId":"9000000000000219","name":"艳阳高照天","avatar":"https://static.tigerbbs.com/ab7a887f7d1ab09c9b3f648ad7c56ad4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000219","authorIdStr":"9000000000000219"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","text":"$诺和诺德(NVO)$决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499743512887688","isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499627205627928,"gmtCreate":1763004718507,"gmtModify":1763004721161,"author":{"id":"4186320050829842","authorId":"4186320050829842","name":"柴房战神","avatar":"https://static.tigerbbs.com/e1b39adb2e2cc51d46292c639c392a5a","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4186320050829842","authorIdStr":"4186320050829842"},"themes":[],"title":"","htmlText":"之前45左右持有过，小赚一笔，弹性确实不如礼来","listText":"之前45左右持有过，小赚一笔，弹性确实不如礼来","text":"之前45左右持有过，小赚一笔，弹性确实不如礼来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/499627205627928","isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000719","authorId":"9000000000000719","name":"AllenBartlett","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000719","authorIdStr":"9000000000000719"},"content":"诺和诺德最近势头不错，可以关注看看","text":"诺和诺德最近势头不错，可以关注看看","html":"诺和诺德最近势头不错，可以关注看看"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":471713787846752,"gmtCreate":1756195941246,"gmtModify":1756195943746,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买， 0成本。 再看看","listText":"没有买， 0成本。 再看看","text":"没有买， 0成本。 再看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/471713787846752","isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469594504081736,"gmtCreate":1755677918721,"gmtModify":1755677920635,"author":{"id":"3575013011868811","authorId":"3575013011868811","name":"小乐食客","avatar":"https://static.tigerbbs.com/2e8da1325093ad58e3fad74a53fed711","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575013011868811","authorIdStr":"3575013011868811"},"themes":[],"htmlText":"老板拿了多少，啥价格啊","listText":"老板拿了多少，啥价格啊","text":"老板拿了多少，啥价格啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469594504081736","isVote":1,"tweetType":1,"viewCount":849,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469523153998048,"gmtCreate":1755660909705,"gmtModify":1755660911759,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买入， 估值有点不敢入手。","listText":"没有买入， 估值有点不敢入手。","text":"没有买入， 估值有点不敢入手。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469523153998048","isVote":1,"tweetType":1,"viewCount":1099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469357378785304,"gmtCreate":1755611450262,"gmtModify":1755613694429,"author":{"id":"9000000000000228","authorId":"9000000000000228","name":"重生之我是鲍威尔","avatar":"https://static.tigerbbs.com/b610f7fa83d7281fe00c102df34d1691","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000228","authorIdStr":"9000000000000228"},"themes":[],"htmlText":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/469357378785304","isVote":1,"tweetType":1,"viewCount":3712,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3575013011868811","authorId":"3575013011868811","name":"小乐食客","avatar":"https://static.tigerbbs.com/2e8da1325093ad58e3fad74a53fed711","crmLevel":5,"crmLevelSwitch":1,"idStr":"3575013011868811","authorIdStr":"3575013011868811"},"content":"老板拿了多少，啥价格啊","text":"老板拿了多少，啥价格啊","html":"老板拿了多少，啥价格啊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469356359631048,"gmtCreate":1755611324134,"gmtModify":1755611326142,"author":{"id":"10000000000010486","authorId":"10000000000010486","name":"理想之城","avatar":"https://static.tigerbbs.com/afa8fd7934742274cc59594904a5c223","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010486","authorIdStr":"10000000000010486"},"themes":[],"htmlText":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469356359631048","isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469255699190144,"gmtCreate":1755595678227,"gmtModify":1755595680393,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买[笑哭]&nbsp;&nbsp;[笑哭]&nbsp;&nbsp; 看着勇士们发财。","listText":"没有买[笑哭]&nbsp;&nbsp;[笑哭]&nbsp;&nbsp; 看着勇士们发财。","text":"没有买[笑哭] [笑哭] 看着勇士们发财。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469255699190144","isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469269980995608,"gmtCreate":1755590112911,"gmtModify":1755590114620,"author":{"id":"9000000000000220","authorId":"9000000000000220","name":"沙漠追光大海逐风","avatar":"https://static.tigerbbs.com/e30b7f24ce0a6599dcdfa3567f958dea","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000220","authorIdStr":"9000000000000220"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","text":"$诺和诺德(NVO)$感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469269980995608","isVote":1,"tweetType":1,"viewCount":1169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469269039907008,"gmtCreate":1755590070513,"gmtModify":1755590946055,"author":{"id":"9000000000000219","authorId":"9000000000000219","name":"艳阳高照天","avatar":"https://static.tigerbbs.com/ab7a887f7d1ab09c9b3f648ad7c56ad4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000219","authorIdStr":"9000000000000219"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","text":"$诺和诺德(NVO)$司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469269039907008","isVote":1,"tweetType":1,"viewCount":951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466933919105112,"gmtCreate":1755014520766,"gmtModify":1755015055063,"author":{"id":"4194685022787260","authorId":"4194685022787260","name":"画夕阳非晚","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4194685022787260","authorIdStr":"4194685022787260"},"themes":[],"htmlText":"哈哈哈哈驴肉火烧确实好吃，刚去保定吃","listText":"哈哈哈哈驴肉火烧确实好吃，刚去保定吃","text":"哈哈哈哈驴肉火烧确实好吃，刚去保定吃","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466933919105112","isVote":1,"tweetType":1,"viewCount":771,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466845447197184,"gmtCreate":1754992506256,"gmtModify":1754992508580,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"都不抄底， 等机会。 宁可错过，不要做错。","listText":"都不抄底， 等机会。 宁可错过，不要做错。","text":"都不抄底， 等机会。 宁可错过，不要做错。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466845447197184","isVote":1,"tweetType":1,"viewCount":923,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466487849685184,"gmtCreate":1754924119457,"gmtModify":1754924121079,"author":{"id":"10000000000010488","authorId":"10000000000010488","name":"欲山行","avatar":"https://static.tigerbbs.com/e460befb8b73628d17452d4795753dfd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010488","authorIdStr":"10000000000010488"},"themes":[],"htmlText":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466487849685184","isVote":1,"tweetType":1,"viewCount":2629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466396157149376,"gmtCreate":1754901733584,"gmtModify":1754901777160,"author":{"id":"9000000000000219","authorId":"9000000000000219","name":"艳阳高照天","avatar":"https://static.tigerbbs.com/ab7a887f7d1ab09c9b3f648ad7c56ad4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000219","authorIdStr":"9000000000000219"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a>礼来都估算600企稳，580最低是吧，那我就估算500-550吧，预估大家的预估求稳还是入XLV吧","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/LLY\">$礼来(LLY)$</a>礼来都估算600企稳，580最低是吧，那我就估算500-550吧，预估大家的预估求稳还是入XLV吧","text":"$礼来(LLY)$礼来都估算600企稳，580最低是吧，那我就估算500-550吧，预估大家的预估求稳还是入XLV吧","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466396157149376","isVote":1,"tweetType":1,"viewCount":1147,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466396159815856,"gmtCreate":1754891149709,"gmtModify":1754891151539,"author":{"id":"4206954846470532","authorId":"4206954846470532","name":"糊涂虫141319","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","crmLevel":9,"crmLevelSwitch":0,"followedFlag":false,"idStr":"4206954846470532","authorIdStr":"4206954846470532"},"themes":[],"htmlText":"错杀那么好的公司，业绩也好，利润也好","listText":"错杀那么好的公司，业绩也好，利润也好","text":"错杀那么好的公司，业绩也好，利润也好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466396159815856","isVote":1,"tweetType":1,"viewCount":682,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"essenList":[{"id":500240556270240,"gmtCreate":1763169542636,"gmtModify":1763169544997,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"title":"","htmlText":"小资金就算了，大资金可以继续看好","listText":"小资金就算了，大资金可以继续看好","text":"小资金就算了，大资金可以继续看好","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/500240556270240","isVote":1,"tweetType":1,"viewCount":15,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499829144248712,"gmtCreate":1763036691021,"gmtModify":1763036693309,"author":{"id":"10000000000010487","authorId":"10000000000010487","name":"买股票的打铁匠","avatar":"https://static.tigerbbs.com/6d94a0a25c35b5c7cdb89db84b17cf5c","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010487","authorIdStr":"10000000000010487"},"themes":[],"htmlText":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"这一波应该能涨到60，下个财报预期已经拉得很低，肯定要来一波触底反弹，明年年初回70 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499829144248712","isVote":1,"tweetType":1,"viewCount":128,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499829382222216,"gmtCreate":1763036749120,"gmtModify":1763036751237,"author":{"id":"10000000000010491","authorId":"10000000000010491","name":"鹿鼎公韦小宝","avatar":"https://static.tigerbbs.com/acbcdba23abf01629ff9868ac714915f","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010491","authorIdStr":"10000000000010491"},"themes":[],"htmlText":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"礼来的口服药都喊出明年上市的口号了，你这边申请半年还没动静，差距太大了 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499829382222216","isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499743670444424,"gmtCreate":1763015823394,"gmtModify":1763015825593,"author":{"id":"9000000000000220","authorId":"9000000000000220","name":"沙漠追光大海逐风","avatar":"https://static.tigerbbs.com/e30b7f24ce0a6599dcdfa3567f958dea","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000220","authorIdStr":"9000000000000220"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","text":"$诺和诺德(NVO)$Nvo现在算是守住2000亿美元总市值底线了。第一反弹目标位，总市值追上阿斯利康。第二反弹目标位，总市值为安进2倍。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499743670444424","isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499743512887688,"gmtCreate":1763015784927,"gmtModify":1763015787212,"author":{"id":"9000000000000219","authorId":"9000000000000219","name":"艳阳高照天","avatar":"https://static.tigerbbs.com/ab7a887f7d1ab09c9b3f648ad7c56ad4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000219","authorIdStr":"9000000000000219"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","text":"$诺和诺德(NVO)$决定在股价现时站不稳50元情况下，止盈4万股诺和诺德。不想仓位太重，预防纳指跌幅过大，短期拖累股价下跌。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499743512887688","isVote":1,"tweetType":1,"viewCount":672,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499677619126864,"gmtCreate":1763016562147,"gmtModify":1763016564839,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"title":"","htmlText":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","listText":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","text":"诺和诺德看好，但是不敢买。 主要还不熟悉美股","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/499677619126864","isVote":1,"tweetType":1,"viewCount":72,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":499627205627928,"gmtCreate":1763004718507,"gmtModify":1763004721161,"author":{"id":"4186320050829842","authorId":"4186320050829842","name":"柴房战神","avatar":"https://static.tigerbbs.com/e1b39adb2e2cc51d46292c639c392a5a","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"4186320050829842","authorIdStr":"4186320050829842"},"themes":[],"title":"","htmlText":"之前45左右持有过，小赚一笔，弹性确实不如礼来","listText":"之前45左右持有过，小赚一笔，弹性确实不如礼来","text":"之前45左右持有过，小赚一笔，弹性确实不如礼来","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/499627205627928","isVote":1,"tweetType":1,"viewCount":77,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"9000000000000719","authorId":"9000000000000719","name":"AllenBartlett","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000719","authorIdStr":"9000000000000719"},"content":"诺和诺德最近势头不错，可以关注看看","text":"诺和诺德最近势头不错，可以关注看看","html":"诺和诺德最近势头不错，可以关注看看"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":462668615676440,"gmtCreate":1753961590334,"gmtModify":1754014951705,"author":{"id":"3519157433193136","authorId":"3519157433193136","name":"美港股观察社","avatar":"https://static.tigerbbs.com/cfcc85fddcd77379cda6138d51be4c17","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3519157433193136","authorIdStr":"3519157433193136"},"themes":[],"title":"暴跌21%！诺和诺德是飞刀还是黄金坑？","htmlText":"诺和诺德股价暴跌逾20%，市值跌破2000亿美元，较其曾经超过6000亿美元的估值大幅缩水。该公司在GLP-1市场面临持续竞争，加之首席执行官离职以及财务指引下调，给公司带来了巨大压力。尽管如此，有外国分析师认为，现在仍是投资者“接住这把飞刀”的好时机，因为该公司的核心业务保持多元化且财务状况稳健。 作者：The Value Portfolio 第一季度业绩 诺和诺德第一季度业绩表现强劲，公司持续朝着目标迈进。 来源：诺和诺德 该公司在糖尿病市场的份额保持强劲，占比33.3%，同比下降0.6%。公司在肥胖症治疗方面的收入高达184亿美元（约合30亿美元），且罕见病领域的销售额也持续表现强劲。即便公司更新了业绩指引，仍预计2025年实现增长。 诺和诺德的GLP-1业务 GLP-1仍是公司最大的销售驱动力，过去几年公司一直在努力维持其市场份额。 来源：诺和诺德 尽管公司面临着持续激烈的竞争，但它在GLP-1市场仍保持全球领先地位。过去3年，公司投入超过200亿美元用于扩大产能和优化生产。预计公司将继续致力于完善其资本组合。 同时，值得注意的是，尽管对公司的业绩指引充斥着各种悲观论调，但它仍然是一家高速增长的公司，服务的患者数量新增数百万。肥胖症是目前人类面临的最致命疾病之一，而该公司在对抗肥胖症方面正取得重大进展。 诺和诺德的其他业务板块 该公司目前非核心业务的GLP-1药物也引发了一些关注。 来源：诺和诺德 公司的罕见病销售额增长了3%，这尤其得益于风险较低且更多元化的国际业务。在国际市场的强劲增长推动下，公司罕见内分泌疾病的销售额也增长了14%。 虽然整体罕见病业务板块规模较小，年销售额约为30亿美元，但它仍是公司业务组合中的重要组成部分。 来源：诺和诺德 公司还专注于核心业务，其口服司美格鲁肽片剂取得了显著成果，且具有良好的安全性。公司已收集了大量相关数据，并提交给FDA","listText":"诺和诺德股价暴跌逾20%，市值跌破2000亿美元，较其曾经超过6000亿美元的估值大幅缩水。该公司在GLP-1市场面临持续竞争，加之首席执行官离职以及财务指引下调，给公司带来了巨大压力。尽管如此，有外国分析师认为，现在仍是投资者“接住这把飞刀”的好时机，因为该公司的核心业务保持多元化且财务状况稳健。 作者：The Value Portfolio 第一季度业绩 诺和诺德第一季度业绩表现强劲，公司持续朝着目标迈进。 来源：诺和诺德 该公司在糖尿病市场的份额保持强劲，占比33.3%，同比下降0.6%。公司在肥胖症治疗方面的收入高达184亿美元（约合30亿美元），且罕见病领域的销售额也持续表现强劲。即便公司更新了业绩指引，仍预计2025年实现增长。 诺和诺德的GLP-1业务 GLP-1仍是公司最大的销售驱动力，过去几年公司一直在努力维持其市场份额。 来源：诺和诺德 尽管公司面临着持续激烈的竞争，但它在GLP-1市场仍保持全球领先地位。过去3年，公司投入超过200亿美元用于扩大产能和优化生产。预计公司将继续致力于完善其资本组合。 同时，值得注意的是，尽管对公司的业绩指引充斥着各种悲观论调，但它仍然是一家高速增长的公司，服务的患者数量新增数百万。肥胖症是目前人类面临的最致命疾病之一，而该公司在对抗肥胖症方面正取得重大进展。 诺和诺德的其他业务板块 该公司目前非核心业务的GLP-1药物也引发了一些关注。 来源：诺和诺德 公司的罕见病销售额增长了3%，这尤其得益于风险较低且更多元化的国际业务。在国际市场的强劲增长推动下，公司罕见内分泌疾病的销售额也增长了14%。 虽然整体罕见病业务板块规模较小，年销售额约为30亿美元，但它仍是公司业务组合中的重要组成部分。 来源：诺和诺德 公司还专注于核心业务，其口服司美格鲁肽片剂取得了显著成果，且具有良好的安全性。公司已收集了大量相关数据，并提交给FDA","text":"诺和诺德股价暴跌逾20%，市值跌破2000亿美元，较其曾经超过6000亿美元的估值大幅缩水。该公司在GLP-1市场面临持续竞争，加之首席执行官离职以及财务指引下调，给公司带来了巨大压力。尽管如此，有外国分析师认为，现在仍是投资者“接住这把飞刀”的好时机，因为该公司的核心业务保持多元化且财务状况稳健。 作者：The Value Portfolio 第一季度业绩 诺和诺德第一季度业绩表现强劲，公司持续朝着目标迈进。 来源：诺和诺德 该公司在糖尿病市场的份额保持强劲，占比33.3%，同比下降0.6%。公司在肥胖症治疗方面的收入高达184亿美元（约合30亿美元），且罕见病领域的销售额也持续表现强劲。即便公司更新了业绩指引，仍预计2025年实现增长。 诺和诺德的GLP-1业务 GLP-1仍是公司最大的销售驱动力，过去几年公司一直在努力维持其市场份额。 来源：诺和诺德 尽管公司面临着持续激烈的竞争，但它在GLP-1市场仍保持全球领先地位。过去3年，公司投入超过200亿美元用于扩大产能和优化生产。预计公司将继续致力于完善其资本组合。 同时，值得注意的是，尽管对公司的业绩指引充斥着各种悲观论调，但它仍然是一家高速增长的公司，服务的患者数量新增数百万。肥胖症是目前人类面临的最致命疾病之一，而该公司在对抗肥胖症方面正取得重大进展。 诺和诺德的其他业务板块 该公司目前非核心业务的GLP-1药物也引发了一些关注。 来源：诺和诺德 公司的罕见病销售额增长了3%，这尤其得益于风险较低且更多元化的国际业务。在国际市场的强劲增长推动下，公司罕见内分泌疾病的销售额也增长了14%。 虽然整体罕见病业务板块规模较小，年销售额约为30亿美元，但它仍是公司业务组合中的重要组成部分。 来源：诺和诺德 公司还专注于核心业务，其口服司美格鲁肽片剂取得了显著成果，且具有良好的安全性。公司已收集了大量相关数据，并提交给FDA","images":[{"img":"https://static.tigerbbs.com/90e4a5f08c3c65151894c0e3f8821d97","width":"1224","height":"861"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":2,"commentSize":2,"repostSize":2,"link":"https://laohu8.com/post/462668615676440","isVote":1,"tweetType":1,"viewCount":10367,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3465877826119039","authorId":"3465877826119039","name":"一雨成烟","avatar":"https://static.tigerbbs.com/467d481c895f6bfd337b50860c3b84e2","crmLevel":8,"crmLevelSwitch":0,"idStr":"3465877826119039","authorIdStr":"3465877826119039"},"content":"这下的不是飞刀，这下的是核弹。","text":"这下的不是飞刀，这下的是核弹。","html":"这下的不是飞刀，这下的是核弹。"},{"author":{"id":"3471339643554752","authorId":"3471339643554752","name":"老猫证劵","avatar":"https://static.tigerbbs.com/4508951e43bda93fa95e2d25e97866f8","crmLevel":8,"crmLevelSwitch":0,"idStr":"3471339643554752","authorIdStr":"3471339643554752"},"content":"最大的风险来自中国山寨","text":"最大的风险来自中国山寨","html":"最大的风险来自中国山寨"}],"imageCount":8,"langContent":"CN","totalScore":0},{"id":462212662313008,"gmtCreate":1753863073081,"gmtModify":1753863202304,"author":{"id":"21347731130544","authorId":"21347731130544","name":"价值投资为王","avatar":"https://static.tigerbbs.com/89ffffc59ff9ac9cb9cb74f596418d44","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"21347731130544","authorIdStr":"21347731130544"},"themes":[],"title":"减肥药巨头单日暴跌23%，开眼了！","htmlText":"昨日，减肥药巨头诺和诺德向市场抛出深水炸弹，宣布下调2025年业绩指引，同时更换CEO，震惊了资本市场！ 受此影响，诺和诺德在哥本哈根交易所的股价暴跌23.1%，创出史上单日最大跌幅记录！在美上市的ADR暴跌21.8%： <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> 诺和诺德是丹麦百年医药巨头，糖尿病及减肥药领域无可争议的霸主，旗下的司美格鲁肽被誉为“减肥神药”！ 一年前，诺和诺德还是资本市场炽手可热的香饽饽，市值一度突破6500亿美元，超越LV，成为欧洲市值最高的企业！市盈率估值曾高达50倍，媲美科技巨头！ 然而，随着减肥药市场竞争加剧，诺和诺德一再下调业绩指引，股价逐步走低。在欧美股市迭创新高的情况下，诺和诺德股价已较最高点下跌63.6%。 至暗时刻下，诺和诺德何去何从？ 从药物类别来看，诺和诺德的收入主要来自糖尿病及减肥药。今年一季度，糖尿病药物营收550.4亿丹麦克朗（约77.7亿美元，下同），减肥药收入184亿，罕见病收入46亿，糖尿病及减肥药占总收入的比重高达94%： 按具体药物来看，今年一季度，降糖药Ozempic贡献了327亿收入，占总收入的比重高达42%；减肥药Wegovy贡献了173.6亿，占总收入比重为22.2%，两种药，占诺和诺德总收入的比例达到64%： Ozempic和Wegovy其实都是司美格鲁肽，原本司美格鲁肽用于降糖，但诺和诺德在临床实验中发现，司美格鲁肽有明显的减重效果，因此，按照不同的剂量，诺和诺德将司美格鲁肽划分为Ozempic和Wegovy，前者用于糖尿病患者控糖，后者用于减肥，两种药本质上是“同一成分、不同适应症和剂量方案”的药物。 在减肥药Wegovy供应短缺时，肥胖人士往往拿Ozempic来替代。 由此可见，司美格鲁肽是诺和诺德的杀手锏，曾带领公司收入走出低谷，2023年的","listText":"昨日，减肥药巨头诺和诺德向市场抛出深水炸弹，宣布下调2025年业绩指引，同时更换CEO，震惊了资本市场！ 受此影响，诺和诺德在哥本哈根交易所的股价暴跌23.1%，创出史上单日最大跌幅记录！在美上市的ADR暴跌21.8%： <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> 诺和诺德是丹麦百年医药巨头，糖尿病及减肥药领域无可争议的霸主，旗下的司美格鲁肽被誉为“减肥神药”！ 一年前，诺和诺德还是资本市场炽手可热的香饽饽，市值一度突破6500亿美元，超越LV，成为欧洲市值最高的企业！市盈率估值曾高达50倍，媲美科技巨头！ 然而，随着减肥药市场竞争加剧，诺和诺德一再下调业绩指引，股价逐步走低。在欧美股市迭创新高的情况下，诺和诺德股价已较最高点下跌63.6%。 至暗时刻下，诺和诺德何去何从？ 从药物类别来看，诺和诺德的收入主要来自糖尿病及减肥药。今年一季度，糖尿病药物营收550.4亿丹麦克朗（约77.7亿美元，下同），减肥药收入184亿，罕见病收入46亿，糖尿病及减肥药占总收入的比重高达94%： 按具体药物来看，今年一季度，降糖药Ozempic贡献了327亿收入，占总收入的比重高达42%；减肥药Wegovy贡献了173.6亿，占总收入比重为22.2%，两种药，占诺和诺德总收入的比例达到64%： Ozempic和Wegovy其实都是司美格鲁肽，原本司美格鲁肽用于降糖，但诺和诺德在临床实验中发现，司美格鲁肽有明显的减重效果，因此，按照不同的剂量，诺和诺德将司美格鲁肽划分为Ozempic和Wegovy，前者用于糖尿病患者控糖，后者用于减肥，两种药本质上是“同一成分、不同适应症和剂量方案”的药物。 在减肥药Wegovy供应短缺时，肥胖人士往往拿Ozempic来替代。 由此可见，司美格鲁肽是诺和诺德的杀手锏，曾带领公司收入走出低谷，2023年的","text":"昨日，减肥药巨头诺和诺德向市场抛出深水炸弹，宣布下调2025年业绩指引，同时更换CEO，震惊了资本市场！ 受此影响，诺和诺德在哥本哈根交易所的股价暴跌23.1%，创出史上单日最大跌幅记录！在美上市的ADR暴跌21.8%： $诺和诺德(NVO)$ 诺和诺德是丹麦百年医药巨头，糖尿病及减肥药领域无可争议的霸主，旗下的司美格鲁肽被誉为“减肥神药”！ 一年前，诺和诺德还是资本市场炽手可热的香饽饽，市值一度突破6500亿美元，超越LV，成为欧洲市值最高的企业！市盈率估值曾高达50倍，媲美科技巨头！ 然而，随着减肥药市场竞争加剧，诺和诺德一再下调业绩指引，股价逐步走低。在欧美股市迭创新高的情况下，诺和诺德股价已较最高点下跌63.6%。 至暗时刻下，诺和诺德何去何从？ 从药物类别来看，诺和诺德的收入主要来自糖尿病及减肥药。今年一季度，糖尿病药物营收550.4亿丹麦克朗（约77.7亿美元，下同），减肥药收入184亿，罕见病收入46亿，糖尿病及减肥药占总收入的比重高达94%： 按具体药物来看，今年一季度，降糖药Ozempic贡献了327亿收入，占总收入的比重高达42%；减肥药Wegovy贡献了173.6亿，占总收入比重为22.2%，两种药，占诺和诺德总收入的比例达到64%： Ozempic和Wegovy其实都是司美格鲁肽，原本司美格鲁肽用于降糖，但诺和诺德在临床实验中发现，司美格鲁肽有明显的减重效果，因此，按照不同的剂量，诺和诺德将司美格鲁肽划分为Ozempic和Wegovy，前者用于糖尿病患者控糖，后者用于减肥，两种药本质上是“同一成分、不同适应症和剂量方案”的药物。 在减肥药Wegovy供应短缺时，肥胖人士往往拿Ozempic来替代。 由此可见，司美格鲁肽是诺和诺德的杀手锏，曾带领公司收入走出低谷，2023年的","images":[{"img":"https://static.tigerbbs.com/d7e0f8ebc864c45f982f1c9b062ca2c0","width":"1623","height":"779"},{"img":"https://static.tigerbbs.com/b6247cd024a7bc95ae4dbb1a201a5ab2","width":"1836","height":"819"},{"img":"https://static.tigerbbs.com/122ec60d6f891dbf75fd133b113bddb2","width":"1392","height":"612"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":4,"commentSize":4,"repostSize":2,"link":"https://laohu8.com/post/462212662313008","isVote":1,"tweetType":1,"viewCount":15324,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"4088209196017200","authorId":"4088209196017200","name":"江江518","avatar":"https://static.tigerbbs.com/b768c9b4c0694bd4a12b0cd1089db1ee","crmLevel":6,"crmLevelSwitch":0,"idStr":"4088209196017200","authorIdStr":"4088209196017200"},"content":"持有NVO又没及时止损，哭死","text":"持有NVO又没及时止损，哭死","html":"持有NVO又没及时止损，哭死"},{"author":{"id":"9000000000000283","authorId":"9000000000000283","name":"雷斯司机","avatar":"https://static.tigerbbs.com/66be84645eeac71f62d4ad271c145cd9","crmLevel":1,"crmLevelSwitch":0,"idStr":"9000000000000283","authorIdStr":"9000000000000283"},"content":"减肥药市场竞争太激烈，小心风险","text":"减肥药市场竞争太激烈，小心风险","html":"减肥药市场竞争太激烈，小心风险"}],"imageCount":10,"langContent":"CN","totalScore":0},{"id":461899854664040,"gmtCreate":1753791900238,"gmtModify":1753843352131,"author":{"id":"3440721572920950","authorId":"3440721572920950","name":"美股解毒师","avatar":"https://static.tigerbbs.com/bbf0f514b8e5abb92266789b89f6e1e6","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3440721572920950","authorIdStr":"3440721572920950"},"themes":[],"title":"减肥药市场大地震！诺和诺德紧急下调全年预期","htmlText":"<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> 原定于8月6日发布二季度财报，但选择提前发布业绩预警。同时也更换了CEO，Maziar Mike Doustda将于8月7日接替Lars Fruergaard Jørgensen。业绩预警与市场反应销售与利润调整： 将2025年全年销售增长预期从13%-21%（CER）下调至8%-14%（CER），营业利润增长从16%-24%下调至10%-16%（CER），显著低于分析师预期的16.6%。 按丹麦克朗计算，销售与利润增长分别再降4%和7%，主因美元贬值。下调的核心驱动来源于Wegovy，在自费渠道（Cash Channel）渗透率低于预期，非法仿制药持续冲击（占处方量约20,000张/周），且保险覆盖渠道扩展缓慢。同时糖尿病药物Ozempic也因美国市场竞争加剧（礼来Zepbound等竞品）受到挤压份额。此外，国际市场部分市场（如欧洲）Wegovy渗透率不及计划。市场直接用脚投票，盘前暴跌25%，一度暴跌28%，最终跌幅收窄至约25%，创2022年以来最大单日跌幅。此次下调被市场视为公司增长逻辑的实质性动摇，尤其Wegovy作为核心增长引擎的可持续性遭质疑。叠加CEO更替（8月7日生效），管理层稳定性亦受关注。如何理解Wegovy增长失速？1. 非法仿制药的持续冲击。尽管FDA于2025年5月22日终止了对GLP-1类药物短缺状态的宽限期，但调研显示非法配制行为仍在持续，以“个性化药物”名义流通，直接分流自费渠道患者。NovoCare药房（自营渠道）每周处方量仅11,000张，但零售自费渠道：约20,000张处方被仿制药分流。 <a href=\"https://laohu8.com/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>","listText":"<a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a> 原定于8月6日发布二季度财报，但选择提前发布业绩预警。同时也更换了CEO，Maziar Mike Doustda将于8月7日接替Lars Fruergaard Jørgensen。业绩预警与市场反应销售与利润调整： 将2025年全年销售增长预期从13%-21%（CER）下调至8%-14%（CER），营业利润增长从16%-24%下调至10%-16%（CER），显著低于分析师预期的16.6%。 按丹麦克朗计算，销售与利润增长分别再降4%和7%，主因美元贬值。下调的核心驱动来源于Wegovy，在自费渠道（Cash Channel）渗透率低于预期，非法仿制药持续冲击（占处方量约20,000张/周），且保险覆盖渠道扩展缓慢。同时糖尿病药物Ozempic也因美国市场竞争加剧（礼来Zepbound等竞品）受到挤压份额。此外，国际市场部分市场（如欧洲）Wegovy渗透率不及计划。市场直接用脚投票，盘前暴跌25%，一度暴跌28%，最终跌幅收窄至约25%，创2022年以来最大单日跌幅。此次下调被市场视为公司增长逻辑的实质性动摇，尤其Wegovy作为核心增长引擎的可持续性遭质疑。叠加CEO更替（8月7日生效），管理层稳定性亦受关注。如何理解Wegovy增长失速？1. 非法仿制药的持续冲击。尽管FDA于2025年5月22日终止了对GLP-1类药物短缺状态的宽限期，但调研显示非法配制行为仍在持续，以“个性化药物”名义流通，直接分流自费渠道患者。NovoCare药房（自营渠道）每周处方量仅11,000张，但零售自费渠道：约20,000张处方被仿制药分流。 <a href=\"https://laohu8.com/S/HIMS\">$Hims &amp; Hers Health Inc.(HIMS)$</a>","text":"$诺和诺德(NVO)$ 原定于8月6日发布二季度财报，但选择提前发布业绩预警。同时也更换了CEO，Maziar Mike Doustda将于8月7日接替Lars Fruergaard Jørgensen。业绩预警与市场反应销售与利润调整： 将2025年全年销售增长预期从13%-21%（CER）下调至8%-14%（CER），营业利润增长从16%-24%下调至10%-16%（CER），显著低于分析师预期的16.6%。 按丹麦克朗计算，销售与利润增长分别再降4%和7%，主因美元贬值。下调的核心驱动来源于Wegovy，在自费渠道（Cash Channel）渗透率低于预期，非法仿制药持续冲击（占处方量约20,000张/周），且保险覆盖渠道扩展缓慢。同时糖尿病药物Ozempic也因美国市场竞争加剧（礼来Zepbound等竞品）受到挤压份额。此外，国际市场部分市场（如欧洲）Wegovy渗透率不及计划。市场直接用脚投票，盘前暴跌25%，一度暴跌28%，最终跌幅收窄至约25%，创2022年以来最大单日跌幅。此次下调被市场视为公司增长逻辑的实质性动摇，尤其Wegovy作为核心增长引擎的可持续性遭质疑。叠加CEO更替（8月7日生效），管理层稳定性亦受关注。如何理解Wegovy增长失速？1. 非法仿制药的持续冲击。尽管FDA于2025年5月22日终止了对GLP-1类药物短缺状态的宽限期，但调研显示非法配制行为仍在持续，以“个性化药物”名义流通，直接分流自费渠道患者。NovoCare药房（自营渠道）每周处方量仅11,000张，但零售自费渠道：约20,000张处方被仿制药分流。 $Hims & Hers Health Inc.(HIMS)$","images":[{"img":"https://static.tigerbbs.com/93a15b1167ef4464b322fc2cd5508094"}],"top":1,"highlighted":1,"essential":2,"paper":2,"likeSize":7,"commentSize":3,"repostSize":7,"link":"https://laohu8.com/post/461899854664040","isVote":1,"tweetType":1,"viewCount":18697,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3441692941897723","authorId":"3441692941897723","name":"悟空的花果山","avatar":"https://static.tigerbbs.com/628f19802db29c1c1a827452d3fe4cb3","crmLevel":8,"crmLevelSwitch":1,"idStr":"3441692941897723","authorIdStr":"3441692941897723"},"content":"nvo 暴雷明显利好礼来， $礼来(LLY)$ 也跟着跌没必要吧","text":"nvo 暴雷明显利好礼来， $礼来(LLY)$ 也跟着跌没必要吧","html":"nvo 暴雷明显利好礼来， $礼来(LLY)$ 也跟着跌没必要吧"},{"author":{"id":"3474501087447989","authorId":"3474501087447989","name":"陈为之","avatar":"https://static.tigerbbs.com/0d8fda2682b25b78a706b6ebca366c7e","crmLevel":8,"crmLevelSwitch":1,"idStr":"3474501087447989","authorIdStr":"3474501087447989"},"content":"如果减肥药整体市场不好，礼来也好不了，而且礼来那么高的估值顶不住的","text":"如果减肥药整体市场不好，礼来也好不了，而且礼来那么高的估值顶不住的","html":"如果减肥药整体市场不好，礼来也好不了，而且礼来那么高的估值顶不住的"}],"imageCount":2,"langContent":"CN","totalScore":0},{"id":471713787846752,"gmtCreate":1756195941246,"gmtModify":1756195943746,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买， 0成本。 再看看","listText":"没有买， 0成本。 再看看","text":"没有买， 0成本。 再看看","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/471713787846752","isVote":1,"tweetType":1,"viewCount":489,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469356359631048,"gmtCreate":1755611324134,"gmtModify":1755611326142,"author":{"id":"10000000000010486","authorId":"10000000000010486","name":"理想之城","avatar":"https://static.tigerbbs.com/afa8fd7934742274cc59594904a5c223","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010486","authorIdStr":"10000000000010486"},"themes":[],"htmlText":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"降价是对的，这药有依赖性，早点养成用药习惯，就能赚几十年的钱。能大幅降价，说明毛利率空间很大。实际上这种药品到最后我觉得更像消费品的逻辑，品牌对用户心智的占据对消费者行为的影响很大，就像万艾可，用的人肯定不在乎原研药贵那点钱。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469356359631048","isVote":1,"tweetType":1,"viewCount":1226,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469357378785304,"gmtCreate":1755611450262,"gmtModify":1755613694429,"author":{"id":"9000000000000228","authorId":"9000000000000228","name":"重生之我是鲍威尔","avatar":"https://static.tigerbbs.com/b610f7fa83d7281fe00c102df34d1691","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000228","authorIdStr":"9000000000000228"},"themes":[],"htmlText":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"这价是2021年的，对比21年和现在的财报，增长速度下降得厉害，感觉至少85-90，耐心拿着吧。AMD就是这么拿过来的，当时天天被空军骂，相信NVO不输AMD的逆。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/469357378785304","isVote":1,"tweetType":1,"viewCount":3712,"authorTweetTopStatus":1,"verified":2,"comments":[{"author":{"id":"3575013011868811","authorId":"3575013011868811","name":"小乐食客","avatar":"https://static.tigerbbs.com/2e8da1325093ad58e3fad74a53fed711","crmLevel":5,"crmLevelSwitch":1,"idStr":"3575013011868811","authorIdStr":"3575013011868811"},"content":"老板拿了多少，啥价格啊","text":"老板拿了多少，啥价格啊","html":"老板拿了多少，啥价格啊"}],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469523153998048,"gmtCreate":1755660909705,"gmtModify":1755660911759,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买入， 估值有点不敢入手。","listText":"没有买入， 估值有点不敢入手。","text":"没有买入， 估值有点不敢入手。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469523153998048","isVote":1,"tweetType":1,"viewCount":1099,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469594504081736,"gmtCreate":1755677918721,"gmtModify":1755677920635,"author":{"id":"3575013011868811","authorId":"3575013011868811","name":"小乐食客","avatar":"https://static.tigerbbs.com/2e8da1325093ad58e3fad74a53fed711","crmLevel":5,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3575013011868811","authorIdStr":"3575013011868811"},"themes":[],"htmlText":"老板拿了多少，啥价格啊","listText":"老板拿了多少，啥价格啊","text":"老板拿了多少，啥价格啊","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469594504081736","isVote":1,"tweetType":1,"viewCount":849,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469269980995608,"gmtCreate":1755590112911,"gmtModify":1755590114620,"author":{"id":"9000000000000220","authorId":"9000000000000220","name":"沙漠追光大海逐风","avatar":"https://static.tigerbbs.com/e30b7f24ce0a6599dcdfa3567f958dea","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000220","authorIdStr":"9000000000000220"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","text":"$诺和诺德(NVO)$感觉新管理层执行力不错，买入的仓位已经盈利，马上即将大幅盈利了……这里随时大幅上拉……","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469269980995608","isVote":1,"tweetType":1,"viewCount":1169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469269039907008,"gmtCreate":1755590070513,"gmtModify":1755590946055,"author":{"id":"9000000000000219","authorId":"9000000000000219","name":"艳阳高照天","avatar":"https://static.tigerbbs.com/ab7a887f7d1ab09c9b3f648ad7c56ad4","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"9000000000000219","authorIdStr":"9000000000000219"},"themes":[],"htmlText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","listText":"<a target=\"_blank\" href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","text":"$诺和诺德(NVO)$司美格鲁肽MASH适应症刚获批，ECHOSENS就与诺和诺德推进合作，提升MASH筛查，看多减肥药这块","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469269039907008","isVote":1,"tweetType":1,"viewCount":951,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":469255699190144,"gmtCreate":1755595678227,"gmtModify":1755595680393,"author":{"id":"3459462368857793","authorId":"3459462368857793","name":"一路走来cd","avatar":"https://static.tigerbbs.com/be085af43e85927a88d1e952e6e9afec","crmLevel":2,"crmLevelSwitch":1,"followedFlag":false,"idStr":"3459462368857793","authorIdStr":"3459462368857793"},"themes":[],"htmlText":"没有买[笑哭]&nbsp;&nbsp;[笑哭]&nbsp;&nbsp; 看着勇士们发财。","listText":"没有买[笑哭]&nbsp;&nbsp;[笑哭]&nbsp;&nbsp; 看着勇士们发财。","text":"没有买[笑哭] [笑哭] 看着勇士们发财。","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/469255699190144","isVote":1,"tweetType":1,"viewCount":798,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":466487849685184,"gmtCreate":1754924119457,"gmtModify":1754924121079,"author":{"id":"10000000000010488","authorId":"10000000000010488","name":"欲山行","avatar":"https://static.tigerbbs.com/e460befb8b73628d17452d4795753dfd","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"10000000000010488","authorIdStr":"10000000000010488"},"themes":[],"htmlText":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","listText":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 <a href=\"https://laohu8.com/S/NVO\">$诺和诺德(NVO)$</a>","text":"耐心等就好，交易量和换手率已经基本回到大跌前了。接下来就等消息面拉升或者下跌，平时波动应该不会太大。 $诺和诺德(NVO)$","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/466487849685184","isVote":1,"tweetType":1,"viewCount":2629,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":465295200919672,"gmtCreate":1754622401133,"gmtModify":1754623028122,"author":{"id":"3571711780449823","authorId":"3571711780449823","name":"FX168财经视频栏目","avatar":"https://static.tigerbbs.com/ff6b06690add160937516097dd4844b9","crmLevel":1,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3571711780449823","authorIdStr":"3571711780449823"},"themes":[],"title":"礼来(LLY)股价现25年最大单日跌幅 更大跌势or难得的抄底机会？","htmlText":"\n \n \n  周四(8月7日)想分析的是最新公布财报的礼来公司，虽然财报本身表现不错，但减肥新药的临床结果不太理想，这令股价出现了大幅下跌。我们就结合财报来看看，这次的财报到底如何？以及这次大跌之后究竟是更大跌势的开端还是重新又出现了不错的抄底机会？\n \n","listText":"周四(8月7日)想分析的是最新公布财报的礼来公司，虽然财报本身表现不错，但减肥新药的临床结果不太理想，这令股价出现了大幅下跌。我们就结合财报来看看，这次的财报到底如何？以及这次大跌之后究竟是更大跌势的开端还是重新又出现了不错的抄底机会？","text":"周四(8月7日)想分析的是最新公布财报的礼来公司，虽然财报本身表现不错，但减肥新药的临床结果不太理想，这令股价出现了大幅下跌。我们就结合财报来看看，这次的财报到底如何？以及这次大跌之后究竟是更大跌势的开端还是重新又出现了不错的抄底机会？","images":[{"img":"https://static.tigerbbs.com/6ba6a1774d2b0bfd68349c8730071840"}],"top":1,"highlighted":1,"essential":1,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/465295200919672","isVote":1,"tweetType":2,"object":{"id":"ed11c51c59ad49c69d92f87739bd0523","tweetId":"465295200919672","videoUrl":"https://1254107296.vod2.myqcloud.com/6d712588vodtransuse1254107296/b5f00e195145403694326023704/v.f30.mp4","poster":"https://static.tigerbbs.com/6ba6a1774d2b0bfd68349c8730071840"},"viewCount":2845,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}]}